Considering Cell Therapy Product “Good Manufacturing Practice” Status

Considering Cell Therapy Product “Good Manufacturing Practice” Status

Bibliographic Details
Main Authors: Patrick Bedford, Juliana Jy, Lucas Collins, Steven Keizer
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Medicine
Subjects:
cell therapy
clinical trials
regulatory
manufacturing
good manufacturing practices
international perspective
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2018.00118/full
id doaj-0adb0cd49bd94771bcfa5fa08a89214a
record_format Article
spelling doaj-0adb0cd49bd94771bcfa5fa08a89214a2020-11-24T22:01:37ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-04-01510.3389/fmed.2018.00118341968Considering Cell Therapy Product “Good Manufacturing Practice” StatusPatrick BedfordJuliana JyLucas CollinsSteven Keizerhttp://journal.frontiersin.org/article/10.3389/fmed.2018.00118/fullcell therapyclinical trialsregulatorymanufacturinggood manufacturing practicesinternational perspective
collection DOAJ
language English
format Article
sources DOAJ
author Patrick Bedford
Juliana Jy
Lucas Collins
Steven Keizer
spellingShingle Patrick Bedford
Juliana Jy
Lucas Collins
Steven Keizer
Considering Cell Therapy Product “Good Manufacturing Practice” Status
Frontiers in Medicine
cell therapy
clinical trials
regulatory
manufacturing
good manufacturing practices
international perspective
author_facet Patrick Bedford
Juliana Jy
Lucas Collins
Steven Keizer
author_sort Patrick Bedford
title Considering Cell Therapy Product “Good Manufacturing Practice” Status
title_short Considering Cell Therapy Product “Good Manufacturing Practice” Status
title_full Considering Cell Therapy Product “Good Manufacturing Practice” Status
title_fullStr Considering Cell Therapy Product “Good Manufacturing Practice” Status
title_full_unstemmed Considering Cell Therapy Product “Good Manufacturing Practice” Status
title_sort considering cell therapy product “good manufacturing practice” status
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2018-04-01
topic cell therapy
clinical trials
regulatory
manufacturing
good manufacturing practices
international perspective
url http://journal.frontiersin.org/article/10.3389/fmed.2018.00118/full
work_keys_str_mv AT patrickbedford consideringcelltherapyproductgoodmanufacturingpracticestatus
AT julianajy consideringcelltherapyproductgoodmanufacturingpracticestatus
AT lucascollins consideringcelltherapyproductgoodmanufacturingpracticestatus
AT stevenkeizer consideringcelltherapyproductgoodmanufacturingpracticestatus
_version_ 1725839326879678464

Similar Items